BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 19593320)

  • 1. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ; Tangchitnob EP; Lepor NE
    Rev Cardiovasc Med; 2009; 10(2):83-90. PubMed ID: 19593320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
    Alexander CJ; Tangchitnob EP; Lepor NE
    Rev Obstet Gynecol; 2009; 2(4):232-9. PubMed ID: 20111659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
    Talbott EO; Zborowskii JV; Boudraux MY
    Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystic ovary syndrome.
    King J
    J Midwifery Womens Health; 2006; 51(6):415-22. PubMed ID: 17081931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome.
    Diamanti-Kandarakis E; Christakou C; Kandarakis H
    Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S; Guzick D
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women.
    Talbott EO; Zborowski JV; Rager JR; Kip KE; Xu X; Orchard TJ
    J Womens Health (Larchmt); 2007 Mar; 16(2):191-7. PubMed ID: 17388735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR; Healy DL
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
    Rachoń D; Teede H
    Mol Cell Endocrinol; 2010 Mar; 316(2):172-9. PubMed ID: 19818376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome.
    Araujo Penna I; Canella PR; Vieira CS; Silva de Sá MF; dos Reis RM; Ferriani RA
    Fertil Steril; 2007 Aug; 88(2):519-22. PubMed ID: 17418836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician.
    Lorenz LB; Wild RA
    Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and polycystic ovary syndrome.
    Galluzzo A; Amato MC; Giordano C
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment.
    Hoyt KL; Schmidt MC
    Clin Lab Sci; 2004; 17(3):155-63. PubMed ID: 15314890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.